Annual Current Liabilities
$6.06 M
-$546.00 K-8.26%
December 31, 2023
Summary
- As of February 8, 2025, ENLV annual total current liabilities is $6.06 million, with the most recent change of -$546.00 thousand (-8.26%) on December 31, 2023.
- During the last 3 years, ENLV annual current liabilities has risen by +$1.69 million (+38.63%).
- ENLV annual current liabilities is now -8.26% below its all-time high of $6.61 million, reached on December 31, 2022.
Performance
ENLV Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Liabilities
$2.79 M
-$50.00 K-1.76%
September 30, 2024
Summary
- As of February 8, 2025, ENLV quarterly total current liabilities is $2.79 million, with the most recent change of -$50.00 thousand (-1.76%) on September 30, 2024.
- Over the past year, ENLV quarterly current liabilities has dropped by -$1.55 million (-35.68%).
- ENLV quarterly current liabilities is now -57.76% below its all-time high of $6.61 million, reached on December 31, 2022.
Performance
ENLV Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
ENLV Current Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -8.3% | -35.7% |
| 3 y3 years | +38.6% | -48.8% |
| 5 y5 years | +436.4% | -48.8% |
ENLV Current Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -8.3% | +28.5% | -57.8% | at low |
| 5 y | 5-year | -8.3% | +38.6% | -57.8% | at low |
| alltime | all time | -8.3% | +7382.7% | -57.8% | +2030.5% |
Enlivex Therapeutics Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $2.79 M(-1.8%) |
| Jun 2024 | - | $2.84 M(-21.3%) |
| Mar 2024 | - | $3.61 M(-40.5%) |
| Dec 2023 | $6.06 M(-8.3%) | $6.06 M(+39.7%) |
| Sep 2023 | - | $4.34 M(-13.1%) |
| Jun 2023 | - | $4.99 M(-8.5%) |
| Mar 2023 | - | $5.45 M(-17.5%) |
| Dec 2022 | $6.61 M(+40.0%) | $6.61 M(+45.9%) |
| Sep 2022 | - | $4.53 M(+7.5%) |
| Jun 2022 | - | $4.21 M(-26.6%) |
| Mar 2022 | - | $5.74 M(+21.7%) |
| Dec 2021 | $4.72 M(+7.9%) | $4.72 M(-0.3%) |
| Sep 2021 | - | $4.73 M(+3.4%) |
| Jun 2021 | - | $4.58 M(-6.8%) |
| Mar 2021 | - | $4.91 M(+12.3%) |
| Dec 2020 | $4.37 M(-26.9%) | $4.37 M(-0.0%) |
| Sep 2020 | - | $4.37 M(-12.7%) |
| Jun 2020 | - | $5.01 M(-6.1%) |
| Mar 2020 | - | $5.34 M(-10.8%) |
| Dec 2019 | $5.98 M | $5.98 M(+31.4%) |
| Sep 2019 | - | $4.55 M(-12.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2019 | - | $5.20 M(+10.8%) |
| Mar 2019 | - | $4.69 M(+315.2%) |
| Dec 2018 | $1.13 M(+145.7%) | $1.13 M(+684.7%) |
| Jun 2018 | - | $144.00 K(-68.7%) |
| Dec 2017 | $460.00 K(-76.2%) | $460.00 K(-14.3%) |
| Sep 2017 | - | $537.00 K(-32.2%) |
| Jun 2017 | - | $792.00 K(-51.1%) |
| Mar 2017 | - | $1.62 M(-16.2%) |
| Dec 2016 | $1.93 M(-23.2%) | $1.93 M(-3.4%) |
| Sep 2016 | - | $2.00 M(+36.2%) |
| Jun 2016 | - | $1.47 M(-32.5%) |
| Mar 2016 | - | $2.17 M(-13.5%) |
| Dec 2015 | $2.51 M(+10.3%) | $2.51 M(+42.7%) |
| Sep 2015 | - | $1.76 M(+1.5%) |
| Jun 2015 | - | $1.74 M(-0.2%) |
| Mar 2015 | - | $1.74 M(-23.7%) |
| Dec 2014 | $2.28 M(+1640.5%) | $2.28 M(+99.0%) |
| Sep 2014 | - | $1.15 M(+60.3%) |
| Jun 2014 | - | $715.00 K(+445.8%) |
| Dec 2013 | $131.00 K(+61.7%) | $131.00 K |
| Dec 2012 | $81.00 K | - |
FAQ
- What is Enlivex Therapeutics annual total current liabilities?
- What is the all time high annual current liabilities for Enlivex Therapeutics?
- What is Enlivex Therapeutics annual current liabilities year-on-year change?
- What is Enlivex Therapeutics quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Enlivex Therapeutics?
- What is Enlivex Therapeutics quarterly current liabilities year-on-year change?
What is Enlivex Therapeutics annual total current liabilities?
The current annual current liabilities of ENLV is $6.06 M
What is the all time high annual current liabilities for Enlivex Therapeutics?
Enlivex Therapeutics all-time high annual total current liabilities is $6.61 M
What is Enlivex Therapeutics annual current liabilities year-on-year change?
Over the past year, ENLV annual total current liabilities has changed by -$546.00 K (-8.26%)
What is Enlivex Therapeutics quarterly total current liabilities?
The current quarterly current liabilities of ENLV is $2.79 M
What is the all time high quarterly current liabilities for Enlivex Therapeutics?
Enlivex Therapeutics all-time high quarterly total current liabilities is $6.61 M
What is Enlivex Therapeutics quarterly current liabilities year-on-year change?
Over the past year, ENLV quarterly total current liabilities has changed by -$1.55 M (-35.68%)